LABU241227C102000
- 0.11
- 0.000.00%
Direxion Daily S&P Biotech Bull 3x Shares ETF Newsroom
AbbVie Retains Humira Market Share Above 70%: Report
Live Stock News: Sideways Trading Market After Big TSMC, UNH Earnings, Philly Economy is Booming
(ALNY) - Analyzing Alnylam Pharmaceuticals's Short Interest
Wall Street Today: JPM and Banking Leads Market Higher
AbCellera Biologics Shares Are Trading Higher After the Company Announced the Expansion of Its Collaboration With AbbVie to Include the Discovery of T-cell Engages in Oncology.
Live Stock: Banks Break the Bank on Earnings, Inflation Looks Tame for Dec
Natera To Provide Roadmap And Outlook At J.P. Morgan Healthcare Conference
Wall Street Today: Market Barely Climbs, Wholesale Inflation Grows Less Than Feared
The Momentum Factor ETF Is Coming off a Great 2024 but Still Oversold
10 Health Care Stocks With Whale Alerts In Today's Session
Live Stock News: Tuesday Market Climbs and TikTok Sale Might be Incoming
AbbVie Goes Ex Dividend Tomorrow
JMP Securities Reiterates Market Perform on Incyteto Market Perform
Incyte At JPM25: Eyes Transformational 2025 With Multiple Drug Launches And Expanding Pipeline
$1000 Invested In Alnylam Pharmaceuticals 15 Years Ago Would Be Worth This Much Today
Wall Street Today: Market Turns Around, Let's See if it Lasts
Unpacking the Latest Options Trading Trends in Amgen
Peering Into Amgen's Recent Short Interest
Live Stock News: Monday Market Falling, 'Too Big to Fail' Earnings to Start Q1 Report Season
Like Bristol-Myers Squibb And AbbVie, Johnson & Johnson Seeks To Bolster Neuropsychiatric Portfolio With $15 Billion Deal